Management of One Positive Blood Culture Set for Streptococcus bovis
Treat this as true bacteremia and initiate appropriate antibiotic therapy while simultaneously pursuing two critical diagnostic workups: evaluation for infective endocarditis and colonoscopy to rule out colorectal neoplasia.
Immediate Clinical Actions
1. Repeat Blood Cultures
Obtain at least 2 additional sets of blood cultures every 24-48 hours until bloodstream clearance is documented 1. While one positive set out of two may represent contamination with some organisms, S. bovis bacteremia—even from a single positive set—warrants serious clinical concern and should not be dismissed as contamination 2, 3.
2. Evaluate for Infective Endocarditis
Strongly consider echocardiography (preferably transesophageal) in all patients with S. bovis bacteremia 1, 2. The evidence shows:
- In one study, 54% of S. bovis patients who underwent echocardiography had valvular vegetations 2
- 24% of S. bovis bacteremia cases presented with definite or possible infective endocarditis 2
- S. bovis biotype I is particularly associated with endocarditis (67% of endocarditis cases) 2
3. Initiate Antibiotic Therapy
Begin treatment immediately with penicillin-based therapy. All S. bovis isolates are typically penicillin-susceptible 4, 2. For penicillin-susceptible strains (MIC ≤0.125 mg/L):
Standard 4-week regimen:
- Penicillin G 12-18 million units/day IV in 4-6 divided doses, OR
- Ceftriaxone 2g once daily IV 4
Alternative 2-week regimen (only for uncomplicated cases WITHOUT endocarditis):
- Penicillin or ceftriaxone PLUS gentamicin or netilmicin 4
Critical caveat: Short-term 2-week therapy should NOT be used if endocarditis is suspected or confirmed 4.
Mandatory Gastrointestinal Workup
Perform colonoscopy during hospitalization to rule out colorectal cancer or adenomatous polyps 4. The evidence is compelling:
- S. bovis (specifically S. gallolyticus subspecies) has a well-documented association with colorectal neoplasia 4, 3
- Among patients who underwent colonoscopy, 47% had colonic lesions (tubular adenomas or carcinomas) 2
- This association is strongest with S. gallolyticus subspecies 4
- If initial colonoscopy is negative, schedule annual colonoscopy surveillance 4
Additional Considerations for GI Workup
- Investigate other intra-abdominal foci, particularly hepatobiliary sources (acute cholecystitis, biliary tract infections), especially with S. bovis biotype II 2
- Consider liver disease screening, particularly in alcoholic patients, as S. bovis bacteremia can be associated with hepatic pathology even without colonic disease 5
Duration of Therapy Based on Clinical Scenario
If Endocarditis is Confirmed:
- Native valve endocarditis: 4 weeks of IV antibiotics (or 2 weeks if combined with aminoglycoside in uncomplicated cases) 4
- Prosthetic valve endocarditis: Minimum 6 weeks of therapy 4
- Count treatment duration from the first day blood cultures become negative, not from the day of diagnosis 1, 4
If No Endocarditis:
- 2-4 weeks of therapy depending on clinical response and source control 4
- Ensure appropriate source control for any identified intra-abdominal pathology
Important Clinical Pitfalls
Do not dismiss a single positive blood culture set as contamination when S. bovis is isolated—this organism is rarely a contaminant and demands full evaluation 2, 3
Do not skip colonoscopy—the colorectal cancer association is too strong to ignore, and this may be the presenting sign of occult malignancy 4, 3
Request biotyping of the isolate if available, as biotype I is more associated with endocarditis while biotype II is more associated with GI/hepatobiliary sources 2
Check for polymicrobial bacteremia—16% of S. bovis cases have concurrent gram-negative bacteremia (especially E. coli), which may indicate an intra-abdominal source 2
Obtain infectious disease consultation at initiation of therapy 1
Prognostic Factors
The 30-day mortality rate for S. bovis bacteremia is approximately 21% 2. High APACHE II scores at presentation are associated with increased mortality, not the organism's antibiotic resistance (which is essentially nonexistent) 2. The presence of underlying malignancy, cardiac disease, diabetes, or liver cirrhosis increases risk 2.